| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tumor Suppressor Protein p53 | 50 | 2025 | 233 | 10.830 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 16 | 2025 | 41 | 4.900 |
Why?
|
| Chromatin | 7 | 2025 | 179 | 2.040 |
Why?
|
| Nuclear Proteins | 8 | 2025 | 330 | 1.920 |
Why?
|
| Proto-Oncogene Proteins | 7 | 2025 | 255 | 1.760 |
Why?
|
| Breast Neoplasms | 13 | 2025 | 1679 | 1.710 |
Why?
|
| Mitomycins | 6 | 2015 | 7 | 1.440 |
Why?
|
| Cell Line, Tumor | 26 | 2025 | 2598 | 1.400 |
Why?
|
| Mutation | 15 | 2025 | 1169 | 1.240 |
Why?
|
| DNA Repair | 3 | 2025 | 196 | 1.240 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2019 | 933 | 1.220 |
Why?
|
| Antineoplastic Agents | 5 | 2024 | 979 | 1.000 |
Why?
|
| DNA Replication | 6 | 2019 | 153 | 0.970 |
Why?
|
| Transcriptional Activation | 5 | 2015 | 173 | 0.930 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2025 | 201 | 0.890 |
Why?
|
| Trans-Activators | 1 | 2025 | 190 | 0.860 |
Why?
|
| Cell Nucleus | 4 | 2020 | 383 | 0.830 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2022 | 3 | 0.790 |
Why?
|
| Signal Transduction | 9 | 2017 | 2111 | 0.730 |
Why?
|
| DNA | 10 | 2024 | 594 | 0.720 |
Why?
|
| DNA, Neoplasm | 4 | 2019 | 92 | 0.690 |
Why?
|
| Electrons | 1 | 2021 | 74 | 0.690 |
Why?
|
| DNA Adducts | 3 | 2010 | 41 | 0.670 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2024 | 78 | 0.650 |
Why?
|
| Piperazines | 3 | 2025 | 117 | 0.650 |
Why?
|
| Humans | 48 | 2025 | 42163 | 0.630 |
Why?
|
| DNA Damage | 12 | 2015 | 358 | 0.620 |
Why?
|
| Neoplasms | 5 | 2015 | 1341 | 0.620 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2015 | 860 | 0.600 |
Why?
|
| Colonic Neoplasms | 1 | 2021 | 223 | 0.600 |
Why?
|
| Genes, p53 | 4 | 2024 | 28 | 0.600 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2019 | 25 | 0.590 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 479 | 0.580 |
Why?
|
| Mutant Proteins | 2 | 2015 | 52 | 0.550 |
Why?
|
| Peptides | 1 | 2020 | 357 | 0.550 |
Why?
|
| Protein Isoforms | 2 | 2018 | 139 | 0.540 |
Why?
|
| Protein Binding | 10 | 2025 | 1076 | 0.510 |
Why?
|
| Adenosine | 2 | 2015 | 62 | 0.500 |
Why?
|
| Imidazoles | 2 | 2025 | 138 | 0.480 |
Why?
|
| Estrogens | 1 | 2017 | 202 | 0.480 |
Why?
|
| Female | 17 | 2025 | 24018 | 0.480 |
Why?
|
| Cell Death | 5 | 2015 | 277 | 0.470 |
Why?
|
| Protein Kinases | 4 | 2015 | 100 | 0.460 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2015 | 49 | 0.460 |
Why?
|
| Cell Proliferation | 5 | 2020 | 1420 | 0.450 |
Why?
|
| Cell Cycle Proteins | 3 | 2025 | 239 | 0.420 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2014 | 41 | 0.420 |
Why?
|
| Vesicular Transport Proteins | 1 | 2014 | 47 | 0.420 |
Why?
|
| Proteome | 1 | 2015 | 150 | 0.410 |
Why?
|
| Estradiol | 2 | 2017 | 269 | 0.410 |
Why?
|
| Alternative Splicing | 1 | 2014 | 92 | 0.410 |
Why?
|
| Caenorhabditis elegans | 1 | 2014 | 78 | 0.400 |
Why?
|
| Transcription, Genetic | 8 | 2015 | 599 | 0.400 |
Why?
|
| Gene Knockdown Techniques | 3 | 2019 | 188 | 0.380 |
Why?
|
| Animals | 23 | 2025 | 16695 | 0.360 |
Why?
|
| Mitomycin | 3 | 2010 | 13 | 0.350 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2025 | 339 | 0.350 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2012 | 115 | 0.340 |
Why?
|
| Mice | 13 | 2025 | 6490 | 0.330 |
Why?
|
| Apoptosis | 7 | 2024 | 1541 | 0.320 |
Why?
|
| Sp1 Transcription Factor | 4 | 2004 | 49 | 0.320 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 1066 | 0.320 |
Why?
|
| Phosphorylation | 5 | 2017 | 973 | 0.320 |
Why?
|
| HIV Long Terminal Repeat | 2 | 2000 | 20 | 0.310 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2014 | 649 | 0.300 |
Why?
|
| Promoter Regions, Genetic | 8 | 2015 | 534 | 0.260 |
Why?
|
| Blotting, Western | 4 | 2015 | 884 | 0.250 |
Why?
|
| RNA, Small Interfering | 3 | 2019 | 436 | 0.250 |
Why?
|
| Camptothecin | 3 | 2001 | 24 | 0.230 |
Why?
|
| RNA Interference | 3 | 2014 | 246 | 0.230 |
Why?
|
| Lipoylation | 1 | 2025 | 17 | 0.230 |
Why?
|
| Up-Regulation | 4 | 2019 | 534 | 0.230 |
Why?
|
| Response Elements | 2 | 2020 | 55 | 0.220 |
Why?
|
| Cell Cycle | 3 | 2001 | 348 | 0.220 |
Why?
|
| Oligonucleotides | 3 | 2020 | 54 | 0.210 |
Why?
|
| Radiation Injuries | 1 | 2024 | 23 | 0.210 |
Why?
|
| Mevalonic Acid | 2 | 2015 | 9 | 0.210 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2025 | 206 | 0.210 |
Why?
|
| BRCA2 Protein | 1 | 2024 | 50 | 0.210 |
Why?
|
| BRCA1 Protein | 1 | 2024 | 58 | 0.210 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 4 | 2012 | 56 | 0.210 |
Why?
|
| Down-Regulation | 2 | 2012 | 452 | 0.200 |
Why?
|
| Protein Footprinting | 1 | 2003 | 1 | 0.200 |
Why?
|
| Protein Kinase C | 1 | 2003 | 124 | 0.200 |
Why?
|
| Chromatography, Affinity | 1 | 2003 | 67 | 0.190 |
Why?
|
| Antigens, Polyomavirus Transforming | 3 | 1992 | 10 | 0.190 |
Why?
|
| Plasmids | 3 | 1993 | 247 | 0.190 |
Why?
|
| Staphylococcus aureus | 3 | 1993 | 91 | 0.190 |
Why?
|
| DNA, Viral | 5 | 2000 | 323 | 0.190 |
Why?
|
| Protein Transport | 2 | 2015 | 295 | 0.190 |
Why?
|
| Bleomycin | 1 | 2001 | 21 | 0.180 |
Why?
|
| Cell Line | 10 | 2004 | 1416 | 0.180 |
Why?
|
| Phthalazines | 1 | 2021 | 4 | 0.180 |
Why?
|
| Cell Survival | 3 | 2015 | 934 | 0.180 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2015 | 74 | 0.180 |
Why?
|
| Mice, Nude | 2 | 2020 | 403 | 0.180 |
Why?
|
| Base Sequence | 9 | 2004 | 997 | 0.170 |
Why?
|
| K562 Cells | 3 | 2006 | 32 | 0.160 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2019 | 21 | 0.160 |
Why?
|
| Gene Silencing | 2 | 2011 | 154 | 0.160 |
Why?
|
| Blotting, Northern | 2 | 2013 | 149 | 0.160 |
Why?
|
| Phenotype | 2 | 2015 | 774 | 0.150 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2020 | 110 | 0.150 |
Why?
|
| History, 21st Century | 1 | 2019 | 85 | 0.150 |
Why?
|
| History, 20th Century | 1 | 2019 | 124 | 0.150 |
Why?
|
| DNA Primers | 2 | 2014 | 295 | 0.150 |
Why?
|
| Leukemia, Myeloid | 3 | 2006 | 9 | 0.150 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2020 | 199 | 0.150 |
Why?
|
| Cyclooxygenase 2 | 1 | 2019 | 106 | 0.140 |
Why?
|
| Receptors, CXCR4 | 1 | 2019 | 74 | 0.140 |
Why?
|
| Estrogen Receptor alpha | 1 | 2019 | 120 | 0.140 |
Why?
|
| E2F1 Transcription Factor | 1 | 2017 | 22 | 0.140 |
Why?
|
| Retinoblastoma Protein | 1 | 2017 | 29 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 4 | 2002 | 506 | 0.130 |
Why?
|
| Proteins | 1 | 2000 | 383 | 0.130 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2017 | 43 | 0.130 |
Why?
|
| DNA-Binding Proteins | 5 | 1993 | 557 | 0.130 |
Why?
|
| Mitosis | 1 | 2017 | 112 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2015 | 32 | 0.120 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 44 | 0.120 |
Why?
|
| Isotope Labeling | 1 | 2015 | 26 | 0.120 |
Why?
|
| Molecular Sequence Data | 8 | 2004 | 1559 | 0.120 |
Why?
|
| Rad51 Recombinase | 1 | 2015 | 7 | 0.110 |
Why?
|
| Cloning, Molecular | 3 | 2008 | 318 | 0.110 |
Why?
|
| Phosphoserine | 1 | 2015 | 21 | 0.110 |
Why?
|
| Protein Stability | 1 | 2015 | 47 | 0.110 |
Why?
|
| Phospholipase D | 2 | 2006 | 50 | 0.110 |
Why?
|
| Neoplasm Metastasis | 2 | 2014 | 233 | 0.110 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 1992 | 50 | 0.110 |
Why?
|
| Aged | 2 | 2018 | 7982 | 0.110 |
Why?
|
| Flow Cytometry | 2 | 2008 | 411 | 0.110 |
Why?
|
| Autophagy | 2 | 2012 | 136 | 0.110 |
Why?
|
| Cytoplasm | 1 | 2015 | 154 | 0.110 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 105 | 0.110 |
Why?
|
| Cell Division | 4 | 2003 | 314 | 0.110 |
Why?
|
| Germ Cells | 1 | 2014 | 74 | 0.100 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 118 | 0.100 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 128 | 0.100 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2008 | 134 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 196 | 0.100 |
Why?
|
| Simian virus 40 | 3 | 1994 | 38 | 0.100 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2012 | 5 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 223 | 0.100 |
Why?
|
| Protein Biosynthesis | 1 | 1993 | 136 | 0.100 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 457 | 0.100 |
Why?
|
| Proteomics | 1 | 2015 | 363 | 0.100 |
Why?
|
| Doxycycline | 1 | 2012 | 32 | 0.100 |
Why?
|
| Binding Sites | 5 | 1998 | 670 | 0.090 |
Why?
|
| Middle Aged | 2 | 2018 | 11819 | 0.090 |
Why?
|
| Oligopeptides | 1 | 2012 | 108 | 0.090 |
Why?
|
| Adult | 3 | 2018 | 13458 | 0.090 |
Why?
|
| Bacterial Proteins | 2 | 1993 | 580 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2014 | 267 | 0.090 |
Why?
|
| Receptors, Estrogen | 1 | 2012 | 177 | 0.090 |
Why?
|
| Models, Biological | 1 | 2015 | 711 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 928 | 0.090 |
Why?
|
| Recombinant Proteins | 4 | 2000 | 522 | 0.090 |
Why?
|
| RNA, Messenger | 2 | 2014 | 1265 | 0.090 |
Why?
|
| Serine | 2 | 2001 | 81 | 0.080 |
Why?
|
| Gene Expression | 1 | 1993 | 692 | 0.080 |
Why?
|
| Cross-Linking Reagents | 2 | 2008 | 51 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2000 | 189 | 0.080 |
Why?
|
| Virus Replication | 2 | 1991 | 318 | 0.080 |
Why?
|
| Chromosomes, Bacterial | 1 | 1989 | 21 | 0.080 |
Why?
|
| Cyclins | 3 | 2000 | 37 | 0.080 |
Why?
|
| Deoxyribonuclease I | 2 | 2000 | 28 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 2803 | 0.070 |
Why?
|
| Etoposide | 1 | 2008 | 21 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 140 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2004 | 1617 | 0.070 |
Why?
|
| Amino Acid Sequence | 4 | 2000 | 1188 | 0.070 |
Why?
|
| Nucleosomes | 2 | 2015 | 31 | 0.060 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2008 | 230 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 1997 | 198 | 0.060 |
Why?
|
| Homozygote | 1 | 2005 | 77 | 0.060 |
Why?
|
| Lipogenesis | 1 | 2025 | 19 | 0.060 |
Why?
|
| Genotype | 1 | 2008 | 796 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2004 | 165 | 0.060 |
Why?
|
| Ubiquitination | 1 | 2025 | 60 | 0.060 |
Why?
|
| Fibroblasts | 2 | 2008 | 278 | 0.050 |
Why?
|
| Transfection | 2 | 2003 | 526 | 0.050 |
Why?
|
| Dactinomycin | 1 | 2003 | 11 | 0.050 |
Why?
|
| Phorbol Esters | 1 | 2003 | 8 | 0.050 |
Why?
|
| Protein Kinase C-delta | 1 | 2003 | 17 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2003 | 42 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2024 | 46 | 0.050 |
Why?
|
| Luciferases | 1 | 2003 | 70 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2024 | 131 | 0.050 |
Why?
|
| Creatine Kinase | 2 | 1992 | 24 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2025 | 658 | 0.050 |
Why?
|
| Models, Molecular | 1 | 2006 | 875 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2001 | 52 | 0.040 |
Why?
|
| Drug Stability | 1 | 2001 | 127 | 0.040 |
Why?
|
| Neomycin | 1 | 2000 | 5 | 0.040 |
Why?
|
| Consensus Sequence | 1 | 2000 | 20 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2004 | 727 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1112 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2002 | 184 | 0.040 |
Why?
|
| Baculoviridae | 2 | 1997 | 14 | 0.040 |
Why?
|
| Restriction Mapping | 2 | 1998 | 45 | 0.040 |
Why?
|
| Androstadienes | 1 | 2000 | 19 | 0.040 |
Why?
|
| Acetylation | 1 | 2000 | 108 | 0.040 |
Why?
|
| Lysine | 1 | 2000 | 120 | 0.040 |
Why?
|
| Spectrophotometry, Infrared | 1 | 1999 | 32 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2015 | 722 | 0.040 |
Why?
|
| Inflammation | 1 | 2024 | 729 | 0.040 |
Why?
|
| TATA Box | 1 | 1998 | 4 | 0.040 |
Why?
|
| DNA Footprinting | 1 | 1998 | 9 | 0.040 |
Why?
|
| Neoplasm Proteins | 2 | 1998 | 228 | 0.040 |
Why?
|
| Genes, Overlapping | 1 | 1997 | 2 | 0.040 |
Why?
|
| Spodoptera | 1 | 1997 | 17 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1993 | 52 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 454 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2015 | 420 | 0.030 |
Why?
|
| Moths | 2 | 1993 | 13 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 1995 | 22 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2015 | 60 | 0.030 |
Why?
|
| Temperature | 3 | 1994 | 314 | 0.030 |
Why?
|
| Antigens, Viral, Tumor | 2 | 1994 | 8 | 0.030 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2015 | 61 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2006 | 136 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 1992 | 97 | 0.030 |
Why?
|
| Elasticity | 1 | 2014 | 50 | 0.030 |
Why?
|
| Osmotic Pressure | 1 | 2014 | 22 | 0.030 |
Why?
|
| Cell Size | 1 | 2014 | 46 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 1995 | 159 | 0.030 |
Why?
|
| Thermolysin | 1 | 1993 | 1 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 1993 | 35 | 0.030 |
Why?
|
| beta-Lactamases | 1 | 1993 | 34 | 0.030 |
Why?
|
| rRNA Operon | 1 | 1992 | 1 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 1992 | 17 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 98 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1993 | 293 | 0.020 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2012 | 3 | 0.020 |
Why?
|
| Prenylation | 1 | 2012 | 4 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 1992 | 217 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2014 | 400 | 0.020 |
Why?
|
| Simvastatin | 1 | 2012 | 29 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 1993 | 301 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 71 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1992 | 167 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 90 | 0.020 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2008 | 29 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 1989 | 207 | 0.020 |
Why?
|
| G1 Phase | 2 | 1999 | 33 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 458 | 0.020 |
Why?
|
| Nucleotides | 1 | 2004 | 37 | 0.010 |
Why?
|
| Age of Onset | 1 | 2004 | 115 | 0.010 |
Why?
|
| Half-Life | 1 | 2004 | 63 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2004 | 203 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2004 | 90 | 0.010 |
Why?
|
| Drosophila | 1 | 2004 | 150 | 0.010 |
Why?
|
| Rats | 1 | 2004 | 3701 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 1995 | 44 | 0.010 |
Why?
|
| CDC2 Protein Kinase | 1 | 1994 | 20 | 0.010 |
Why?
|
| Glutaral | 1 | 1993 | 4 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1993 | 19 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1993 | 52 | 0.010 |
Why?
|
| Histidine | 1 | 1993 | 44 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1993 | 95 | 0.010 |
Why?
|
| Muscles | 1 | 1992 | 84 | 0.010 |
Why?
|
| Hela Cells | 1 | 1992 | 370 | 0.010 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 1990 | 9 | 0.010 |
Why?
|
| Acetaldehyde | 1 | 1990 | 11 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1992 | 491 | 0.010 |
Why?
|
| Male | 1 | 2004 | 22779 | 0.000 |
Why?
|